Alltop RSS: Medivation cancer drug impresses; shares double

Alltop RSS Alltop RSS feed for pregnancy.alltop.com

Medivation cancer drug impresses; shares double Nov 3rd 2011, 15:15 An experimental prostate cancer drug from Medivation Inc helped patients live longer in a late-stage study, sending the company's shares soaring on hopes that it will become a strong contender in an estimated $9 billion market.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions